Live Breaking News & Updates on Aldeyra Therapeutics Company Profile

Stay updated with breaking news from Aldeyra therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aldeyra Therapeutics' (ALDX) Outperform Rating Reaffirmed at Oppenheimer

Aldeyra Therapeutics' (ALDX) Outperform Rating Reaffirmed at Oppenheimer
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los Angeles , United States , Bruce Greenberg , Denali Advisors , Perceptive Advisors Llc , Kingswood Wealth Advisors , Woodstock Corp , Aldeyra Therapeutics Company Profile , Los Angeles Capital Management , Aldeyra Therapeutics , Free Report , Get Free Report , Financial Markets , Wealth Advisors , Angeles Capital Management , Scavenger Receptor , Aldeyra Therapeutics Daily ,

Aldeyra Therapeutics (NASDAQ:ALDX) Earns Buy Rating from HC Wainwright

Aldeyra Therapeutics (NASDAQ:ALDX) Earns Buy Rating from HC Wainwright
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Ptoddc Brady , Aldeyra Therapeutics Company Profile , Capital Investment Advisors , Sg Americas Securities , Northrock Partners , Perceptive Advisors Llc , Aldeyra Therapeutics , Free Report , Aldeyra Therapeutic , Therapeutics Trading Down , Get Free Report , Rock Partners , Investment Management , Pale Fire Capital , Scavenger Receptor , Aldeyra Therapeutics Daily ,

Perceptive Advisors Llc Buys 37,712 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc purchased 37,712 shares of the stock in a transaction dated Friday, April 5th. The shares were acquired at an average price of $4.74 per share, with a total value of $178,754.88. Following the completion of the acquisition, the insider now owns 9,275,851 […] ....

Perceptive Advisors Llc , Boothbay Fund Management , Citigroup Inc , Ameriprise Financial Inc , Aldeyra Therapeutics Company Profile , Aldeyra Therapeutics Inc , Cetera Advisor Networks , Aldeyra Therapeutics , Get Free Report , Advisors Llc , Therapeutics Trading Down , Point Capital Management , Advisor Networks , Fund Management , Scavenger Receptor , Aldeyra Therapeutics Daily ,

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Increased to Outperform at Oppenheimer

Oppenheimer upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Wednesday morning, MarketBeat reports. They currently have $10.00 target price on the biotechnology company’s stock. ALDX has been the subject of several other research reports. StockNews.com upgraded Aldeyra […] ....

Bruce Greenberg , Perceptive Advisors Llc , Capital Investment Advisors , Northrock Partners , Tower Research Capital , Ameritas Investment Partners Inc , Securities Exchange Commission , Aldeyra Therapeutics Company Profile , Sg Americas Securities , Aldeyra Therapeutics , Free Report , Get Free Report , Exchange Commission , Investment Partners , Research Capital , Scavenger Receptor , Aldeyra Therapeutics Daily ,